Cancer Care Ontario | Cancer Care Ontario

416 Results

Guidelines and Advice

Exercise for People with Cancer

Status: Current
ID: 19-5
Version: 2

Jul 2024

Guidelines and Advice

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Status: Current
ID: 2-29
Version: 4

Feb 2024

Guidelines and Advice

Follow-up and Surveillance of Curatively Treated Lung Cancer Patients

Status: Current
ID: 26-3
Version: 2

Feb 2024

Guidelines and Advice

Management of Ductal Carcinoma in Situ of the Breast

Status: Current
ID: GL1-10
Version: 4

Mar 2024

Guidelines and Advice

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Status: Education and Information
ID: 2-12
Version: 2

Oct 2013

Guidelines and Advice

Organizational Guideline for Gynecologic Oncology Services in Ontario

Status: In-Review
ID: 4-11

Jun 2013

Guidelines and Advice

Comparison of PET/CT and PET/MR Imaging in Oncology

Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Guidelines and Advice

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

Guidelines and Advice

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Status: Education and Information
ID: 7-12 Version 2
Version: 2

May 2013

Guidelines and Advice

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Status: Archived
ID: MOAC 1

Nov 2013

Guidelines and Advice

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

Status: Current
ID: SCT 5

Aug 2013

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2011 to June 2012

Status: Current
ID: PET 2012-1

Sep 2013

Exercise for People with Cancer

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Follow-up and Surveillance of Curatively Treated Lung Cancer Patients

Management of Ductal Carcinoma in Situ of the Breast

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Organizational Guideline for Gynecologic Oncology Services in Ontario

Comparison of PET/CT and PET/MR Imaging in Oncology

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2011 to June 2012

Pages